Xelcis Bio™ is pioneering a new era in targeted cancer therapeutics through our proprietary TRIDENT™ delivery platform. For our lead program, we combine cutting-edge nanoparticle technology with chemotherapy to create precisely targeted therapies that enhance effectiveness while reducing side effects. At Xelcis Bio™, we're not just improving existing treatments —we're transforming the way cancer care is delivered, with the goal of better outcomes and improved quality of life for patients worldwide.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 867 Boylston St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.xelcisbio.com
- Keywords
- Overcomers Counseling.
- HQ
- Boston, Massachusetts
Xelcis Bio Inc. Questions
Xelcis Bio Inc.'s website is http://www.xelcisbio.com
Xelcis Bio Inc.'s LinkedIn profile is https://www.linkedin.com/company/xelcis-bio
Xelcis Bio Inc. has
3 employees.
View email and phone details for 3
employees at Xelcis Bio Inc..
Xelcis Bio Inc.'s industry is
Biotechnology Research
Xelcis Bio Inc.'s top competitors are
Paratope Bio Inc.,
Fraxional,
Tasca Therapeutics,
Parallel Immunotherapeutics Inc.,
Fogarty Knapp & Associates, Inc.,
Maplight Therapeutics, Inc.,
Owl Bio Advisors,
Hesta Health,
Astrogen, Inc.,
Overcomers Counseling.
Xelcis Bio Inc.'s categories are Biotechnology Research
Xelcis Bio Inc.'s founding year is 2024
